Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Clinical Pathology 2002;55:627-628; doi:10.1136/jcp.55.8.627
Copyright © 2002 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.
Journal of Clinical Pathology 2002;55:627-628
© 2002 Journal of Clinical Pathology

SHORT REPORT

Laboratory investigations following an unexpectedly positive crossmatch result in a patient awaiting renal transplantation

J Cole1, A Wortley1, J Stoves2, B Clark1

1 Transplant and Cellular Immunology, St James's University Hospital, Leeds LS9 7TF, UK
2 Department of Renal Medicine, St James's University Hospital

Correspondence to:
Correspondence to:
Dr B Clark, Transplant and Cellular Immunology, St James's University Hospital, Leeds LS9 7TF, UK;
Brendan.Clarke{at}leedsth.nhs.uk

ABSTRACT

In the preparation of patients for renal transplantation tests of human leucocyte antigen (HLA) sensitisation are performed to detect "unacceptable" HLA antigens that, if present on donor cells, would be expected to result in a positive crossmatch. Individuals bearing such specificities may then be excluded from consideration as donors. Unexpected positive crossmatch results are sometimes obtained when a serum specificity has not been detected on screening. Failure to identify a donor relevant HLA antibody in a recipient at the time of crossmatch may result in hyperacute rejection of the graft. This report describes laboratory investigations performed after a positive crossmatch result in a live donor situation. The pattern of crossmatch results indicated that reactivity resulted from HLA class I antibody. Previously performed serum screening using a standard complement dependent cytotoxicity technique had failed to identify donor relevant antibody specificities in the recipient. Retrospective flow cytometric screening of the same serum samples identified an HLA-A24 specificity of donor relevance. The lower sensitivity of methods used for routine serum screening compared with those used for crossmatching accounts for the findings in this case. The laboratory has amended its serum screening protocol to include flow cytometric analysis.

Keywords: renal transplantation; serum screening; crossmatch

Abbreviations: CDC, complement dependent cytotoxicity; HLA, human leucocyte antigen


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs